Antibodies detected in samples from 21,730 pregnant women

1.Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Scientific Publications, 1997.Search in Google Scholar

2.Tijanic N, Jovanovic-Srzentic S, Djokic M. Importance of laboratory analysis in antenatal testing. Bilt Hematol Transfuz 1996;1:11-3.Search in Google Scholar

3.Slavkovic B, Vavic N, Pajevic M, Paunovic D, Djokic M. Incidence of red cell antibodies during pregnancy. Bilt Hematol Transfuz 1994;2:49-51.Search in Google Scholar

4.Cepulic-Golubic et al. RhD immunoprophylaxis in pregnancy. Zagreb: Klinickatransfuziologija, 2000.Search in Google Scholar

5.Muhlbacher A, Michl U. Prevalence rate of red blood cell antibodies during gravidity in the Federal province Salzburg. Infusionsther Transfusionsmed 1999;26:348-52.10.1159/000053518Search in Google Scholar

6.Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies correlated to the outcome of the newborn. A 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995;74:687-92.10.3109/00016349509021175Search in Google Scholar

7.Brecker M, ed. Technical manual. 14th ed. Bethesda, MD: American Association of Blood Banks, 2003.Search in Google Scholar

8.Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-83.10.1046/j.1537-2995.1990.30290162907.xSearch in Google Scholar

9.Contreras M, Garners SF. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995;59-63.Search in Google Scholar

10.Garratty G. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn, Vox Sang 1995;64-9.10.1111/j.1423-0410.1995.tb00349.xSearch in Google Scholar

11.Daniels G. Human blood groups. Oxford: Blackwell Science,1995.Search in Google Scholar

12.Zupanska B. Clinical significance of alloantibodies. In: red cell immunohaematology. Proceedings of the European School of Transfusion Medicine 1998; 59-66.Search in Google Scholar

13.Bowell PJ, Inskip MJ, Jones MN. The significance of anti-C alloimmunization in pregnancy. Clin Lab Haematol 1988;10:251-5.10.1111/j.1365-2257.1988.tb00018.xSearch in Google Scholar

14.Cheepsattayacorn R, Fongsatitkul L, Chotinaruemol S, et al. Anti-E as a cause of hemolytic disease of the newborn. J Med Assoc Thai 1997;Sep.80(Suppl 1).Search in Google Scholar

15.Bowell PJ, Brown SE, Dike AE, et al. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 1986;93:1044-8.10.1111/j.1471-0528.1986.tb07829.xSearch in Google Scholar

16.Lin SV, Lin DT, Hisieh SW, et al. Hemolytic disease of the newborn caused by anti-M antibody. J Formos Med Assoc 1996;95:390-2.Search in Google Scholar

17.De Yong-Owens, Kennedy M, Rose RL, et al. Anti-M isoimmunization management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 1997;90:962-6.10.1016/S0029-7844(97)00476-6Search in Google Scholar

18.Hadley AG. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn. Vox Sang 1998;74(Suppl 2):375-83.10.1111/j.1423-0410.1998.tb05445.xSearch in Google Scholar

19.Moise KJ Jr. Non-anti-D antibodies in red cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;Sep;92(1):75-81.10.1016/S0301-2115(00)00428-0Search in Google Scholar

20.Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445-52.10.1046/j.1537-2995.2001.41111445.x11724993Search in Google Scholar